Filing Details

Accession Number:
0001555280-22-000221
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-26 16:36:41
Reporting Period:
2022-07-22
Accepted Time:
2022-07-26 16:36:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1555280 Zoetis Inc. ZTS Pharmaceutical Preparations (2834) 460696167
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1567878 Roxanne Lagano C/O Zoetis Inc.
10 Sylvan Way
Parsippany NJ 07054
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-07-22 1,163 $73.24 24,850 No 4 M Direct
Common Stock Acquisiton 2022-07-22 1,004 $87.51 25,854 No 4 M Direct
Common Stock Disposition 2022-07-22 2,167 $180.26 23,687 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2022-07-22 1,163 $0.00 1,163 $0.00
Common Stock Stock Option Disposition 2022-07-22 1,004 $0.00 1,004 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
38,573 No 4 M Direct
37,569 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
  2. The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
  3. Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  4. 1,163 options granted February 13, 2018 at an exercise price of $73.24 per option.
  5. Each option vests on the third anniversary of the date of grant.
  6. Each option expires on the tenth anniversary of the date of grant.
  7. 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 9,040 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
  8. 1,004 options granted February 12, 2019 at an exercise price of $87.51 per option.
  9. 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.